Dexilant
In brief
- In our pharmacy, you can buy dexilant without a prescription, with delivery across the United Kingdom and discreet packaging available.
- Dexilant (dexlansoprazole) is used to treat gastro-oesophageal reflux disease (GERD) and erosive oesophagitis; it is a proton pump inhibitor that suppresses stomach acid by inhibiting the H+/K+ ATPase in gastric parietal cells and uses a dual delayed‑release system for prolonged acid control.
- Usual doses are 30 mg once daily for symptomatic GERD and maintenance, and 60 mg once daily for healing erosive oesophagitis (treatment durations commonly up to 4–8 weeks for healing and up to 6 months for maintenance); adolescents 12–17 years use the same doses as adults.
- The drug is administered orally as delayed‑release capsules (commonly 30 mg and 60 mg).
- Dexilant begins to reduce gastric acid within about 1 hour, with many patients noticing symptom improvement within 1–3 days; maximal effect may take several days of treatment.
- Each dose gives up to 24 hours of acid suppression due to the dual delayed‑release formulation; prescribed treatment courses vary (healing up to 8 weeks, maintenance up to 6 months).
- Avoid excessive alcohol — alcohol can worsen reflux symptoms and increase gastrointestinal side effects; it is advisable to limit alcohol while taking Dexilant.
- The most common side effect is diarrhoea; other common effects include nausea, abdominal pain, flatulence and headache.
- Would you like to try dexilant without a prescription?
Market Realities And Patient Experiences
- INN (International Nonproprietary Name): Dexlansoprazole
- Brand Names Available In United Kingdom: Dexilant (may be marketed as dexlansoprazole by generic suppliers)
- ATC Code: A02BC06 — Drugs For Acid‑Related Disorders; Proton Pump Inhibitors
- Forms & Dosages: Capsule; 30mg, 60mg; oral; blister strip and bottles; all forms are delayed‑release with a dual delayed gastric dissolution system
- Manufacturers In United Kingdom: Original manufacturer Takeda Pharmaceuticals; local generic suppliers may register following exclusivity period
- Registration Status In United Kingdom: EMA/Europe approved; prescription status — Rx Only
- OTC / Rx Classification: Rx Only
Availability, Cost And Patient Sentiment
Dexilant (INN: dexlansoprazole) is a branded delayed‑release proton pump inhibitor available as 30mg and 60mg capsules.
Patients in the UK obtain it either on NHS prescription or by paying privately from retail chains such as Boots, LloydsPharmacy and Superdrug, or via online pharmacies and electronic prescriptions.
Regional prescription policies affect uptake: prescriptions are free in Scotland, Wales and Northern Ireland while prescription charges apply in England.
Many patients choose Dexilant for its convenience and the dual delayed‑release formulation, which reduces strict meal timing compared with many other PPIs.
Concerns commonly reported include long‑term side effects, the cost of the branded product and repeat prescribing logistics.
Top Five Pros
- Less strict meal timing compared with some PPIs.
- Good night‑time symptom control for many patients.
- Licensed for adolescents aged 12 and above.
- Available in two standard strengths for induction and maintenance.
- Dual release may aid adherence for irregular schedules.
Top Five Cons
- Branded cost is higher than many generic PPIs.
- Some patients worry about long‑term safety signals linked to prolonged PPI use.
- Requires a prescription in major markets.
- Not suitable for everyone with severe hepatic impairment.
- Potential interactions with certain antiretrovirals (e.g., rilpivirine).
| Retail Pathway | NHS Pathway |
|---|---|
| Private purchase from Boots, LloydsPharmacy, Superdrug or online pharmacies. | Prescribed by GP or hospital clinician and dispensed via NHS pharmacy or community provider. |
| Pay the branded price or choose generic alternatives where available. | Subject to local formulary decisions; free in Scotland/Wales/NI, chargeable in England. |
| Electronic prescription and home delivery growing in popularity. | Repeat prescribing and electronic repeat dispensing simplify ongoing supply for chronic users. |
Product Positioning — Who Dexilant Is For
Indications, Age Groups And Clinical Niches
Which patients are most likely to be prescribed Dexilant?
Dexilant is licensed as a prescription PPI for symptomatic gastro‑oesophageal reflux disease (GERD) and for healing erosive oesophagitis in adults and adolescents aged 12 and older.
Typical clinical uses are short‑term healing of erosive disease and longer‑term maintenance to prevent relapse after healing.
- Erosive Oesophagitis
- Induction: 60mg once daily for up to 8 weeks to promote mucosal healing.
- Maintenance Therapy
- Maintenance: 30mg once daily for up to 6 months to reduce relapse risk.
- Symptomatic GERD
- Symptom control: 30mg once daily for up to 4 weeks for relief of heartburn and regurgitation.
- Adolescents
- Same dosing as adults for patients aged 12–17 years where indicated.
| Indication | Dose | Typical Duration |
|---|---|---|
| Erosive Oesophagitis (Healing) | 60mg once daily | Up to 8 weeks |
| Maintenance After Healing | 30mg once daily | Up to 6 months |
| Symptomatic GERD | 30mg once daily | Up to 4 weeks |
Ideal Patient Profile
- Frequent day and/or night‑time reflux symptoms not controlled by lifestyle measures.
- Confirmed erosive oesophagitis requiring healing therapy.
- Patients with irregular meal patterns or shift workers who would benefit from less meal‑dependent dosing.
- Adolescents aged 12 years or older with erosive disease.
- Those who have experienced adherence difficulties with meal‑timed PPIs.
Forms, Packaging And Storage (Retail Detail)
What Pharmacies Stock And How To Advise On Storage
Dexilant is supplied as delayed‑release capsules in 30mg and 60mg strengths.
Packaging varies by market and supplier and commonly includes blister strips and bottles for retail sale.
Original manufacturer is Takeda, with generics available in markets following patent expiry.
Store capsules below 30°C in a dry place and keep in the original packaging to protect from moisture.
| Form | Dose | Packaging | Route |
|---|---|---|---|
| Capsule (Delayed‑Release) | 30mg | Blister strip, bottles | Oral |
| Capsule (Delayed‑Release) | 60mg | Blister strip, bottles | Oral |
For dispense pages include fields for pack size options, SKU, batch number and expiry date.
Advise patients to avoid exposure to excessive heat or moisture and not to freeze capsules.
Dosing Regimens In Practice
Standard Doses, Missed Dose And Overdose Guidance
How should patients take Dexilant and what should they do if they miss a dose?
Symptomatic GERD and maintenance commonly use 30mg once daily.
Erosive oesophagitis healing typically uses 60mg once daily for up to 8 weeks followed by 30mg maintenance for up to 6 months.
Adolescents aged 12 and older follow the adult dosing recommendations.
| Condition | Dose | Duration |
|---|---|---|
| Erosive Oesophagitis (Healing) | 60mg once daily | Up to 8 weeks |
| Maintenance Therapy | 30mg once daily | Up to 6 months |
| Symptomatic GERD | 30mg once daily | Up to 4 weeks |
Missed dose: take as soon as remembered unless it is almost time for the next dose; do not double up doses.
Overdose: seek emergency medical attention; there is no specific antidote and management is supportive.
On product pages show clear “How to take” bullets and note the timing flexibility compared with traditional PPIs.
Counsel on swallowability — capsules should be swallowed whole and not crushed unless advice from a clinician permits alternative administration.
How The Dual Delayed‑Release Formulation Affects Use
Mechanism Simplified For Patients And Adherence Benefits
What is “dual delayed‑release” and why does it matter?
Dexilant capsules use a dual delayed‑release system that produces two separate releases of dexlansoprazole along the gastrointestinal tract.
This results in prolonged acid suppression and less strict dependence on dosing relative to meals compared with many single‑release PPIs.
For patients this generally means fewer timing errors, better control of night‑time symptoms for some users and simpler adherence for those with irregular schedules.
| Phase | Approximate Action |
|---|---|
| First Release | Early absorption to reduce daytime acid peaks. |
| Second Release | Delayed absorption to extend acid suppression into night-time hours. |
Short FAQ
- Can Dexilant be taken with or without food? — The dual release reduces strict meal dependency compared with many classic PPIs.
- Can the capsule be opened? — Do not crush or open the capsule without consulting a clinician; the formulation is designed for intact release.
- Will timing changes matter? — There is increased flexibility, but try to take the dose at roughly the same time each day for best adherence.
Contraindications And Clinical Cautions
Absolute And Relative Contraindications Pharmacy Checks
Which conditions make Dexilant unsuitable or require extra caution?
| Absolute Contraindications | Relative Cautions |
|---|---|
| Hypersensitivity to dexlansoprazole, other PPIs, or excipients | Severe hepatic dysfunction — use lowest effective dose for moderate impairment; not recommended in severe impairment |
| Co‑administration with products containing rilpivirine (contraindicated) | History of osteoporosis or fracture risk — monitor bone health for prolonged high‑dose use |
| Acute severe hepatic impairment | Risk of masking gastric malignancy — investigate unexplained GI alarm symptoms before prolonged PPI therapy |
- Severe Hepatic Impairment
- Refers to marked reduction in liver function; Dexilant is not recommended in this setting due to lack of safety data.
- Moderate Hepatic Impairment
- Use the lowest effective dose and monitor clinically.
- Renal Impairment
- No routine dose adjustment is required as primary metabolism is hepatic.
Adverse Effects And Monitoring
Common Side Effects And Long‑Term Safety Signals
What should patients expect and what should be monitored if use is prolonged?
Common adverse events reported include diarrhoea, nausea, abdominal pain and flatulence.
Headache and upper respiratory tract infections are occasional findings in trial and post‑marketing data.
Long‑term safety signals associated with prolonged PPI use include hypomagnesaemia and vitamin B12 deficiency, increased fracture risk with prolonged high‑dose therapy and a possible increased risk of Clostridioides difficile infection in extended courses.
For repeat or prolonged prescriptions consider baseline and periodic checks where clinically indicated, such as magnesium levels and assessment of B12 if symptomatic.
| Adverse Event | Frequency | Notes |
|---|---|---|
| Diarrhoea | Common | Usually self‑limiting; report if persistent |
| Nausea | Common | Mild GI discomfort |
| Abdominal Pain | Common | May resolve with continued use |
| Flatulence | Common | Generally mild |
| Headache | Occasional | Mild‑to‑moderate |
| Upper Respiratory Tract Infection | Occasional | Noted more with long‑term use |
Advise patients to report persistent diarrhoea, severe abdominal pain or new neurological symptoms promptly.
Interactions And Polypharmacy Considerations
Key Drug Interactions And Pharmacy Screening Steps
Which medicines require active screening when dispensing Dexilant?
Co‑administration with rilpivirine is contraindicated due to clinically significant interactions.
Drugs where absorption is pH‑dependent, such as atazanavir and certain antifungals, may be affected by acid suppression and require review.
Warfarin and other drugs metabolised by CYP enzymes should be monitored for potential interaction effects.
| Drug/Class | Interaction Risk | Recommended Action |
|---|---|---|
| Rilpivirine (antiretroviral) | High — contraindicated | Do not co‑prescribe; contact prescriber |
| Atazanavir | Absorption reduced by increased gastric pH | Review regimen; consider alternatives |
| Warfarin | Possible altered INR | Monitor INR after initiation or change |
| Tacrolimus / Methotrexate | Potential interaction risk in polypharmacy | Pharmacist‑led reconciliation and prescriber liaison advised |
Checklist for pharmacy screening: always check for antiretrovirals, interacting antifungals, antiplatelet or anticoagulant therapy and other narrow therapeutic index drugs.
Clinical Efficacy Summary For Product Pages
Key Trial Outcomes And Approval Rationale
What evidence supports Dexilant’s licensed uses?
Regulatory approvals for Dexilant cover healing of erosive oesophagitis and maintenance therapy, as well as symptomatic GERD control, supported by clinical trials showing healing rates at 60mg and reduced relapse on 30mg maintenance.
Comparative trials indicate broadly similar acid suppression to other PPIs but with distinct timing flexibility stemming from the dual release formulation.
Decision to use Dexilant over another PPI is frequently influenced by adherence, lifestyle factors and adolescent licence rather than large efficacy differences in acid suppression.
| Indication | Key Outcome | Typical Duration |
|---|---|---|
| Erosive Oesophagitis Healing | Higher healing rates reported with 60mg induction vs baseline | Up to 8 weeks |
| Maintenance Therapy | Reduced relapse on 30mg maintenance vs placebo | Up to 6 months |
| Symptomatic GERD | Symptom relief with 30mg daily | Up to 4 weeks |
Include links to SmPC and MHRA or EMA summaries on product pages for transparency and regulatory context.
Regulatory, Patent And Generic Landscape (UK Focus)
Licensing, Prescription Status And Generics
Dexilant is a prescription‑only medicine in major markets and its licensed indications include GERD and erosive oesophagitis.
Takeda is the original manufacturer and generics may be available in markets following patent expiry.
Pharmacies may supply generics where licensed; prescribers may request brand prescribing where clinically indicated.
| Stage | Notes |
|---|---|
| Originator | Takeda Pharmaceuticals |
| Patent/Exclusivity | Patent expiry allowed generic entry in several markets |
| Generic Entry | Local generic suppliers may register following exclusivity period |
Check MHRA and EMA listings for the current marketing authorisations and for details on UK registration status.
Buying Pathways And NHS Reimbursement In The UK
NHS Prescribing, Private Purchase And Online Pharmacy Options
Dexilant is prescription‑only and available on NHS prescriptions where clinically indicated, subject to local formulary decisions.
Private purchase prices vary across major retail chains and online pharmacies.
Regional differences matter: prescriptions are free in Scotland, Wales and Northern Ireland, while prescription charges apply in England.
Electronic prescriptions and repeat dispensing can simplify supply for chronic users.
In our online pharmacy, dexilant is available without a prescription, with discreet delivery to United Kingdom in 5‑14 days.
| Product | Typical Branded Price | Generic Option |
|---|---|---|
| Dexilant (branded) | Varies by retailer | May be more expensive than generic PPIs |
| Generic Dexlansoprazole | Typically lower than branded product where available | Substitution depends on licence and prescriber preference |
How to get on NHS repeat: speak to your GP about suitability for repeat prescribing and arrange electronic repeat dispensing where long‑term therapy is indicated and safe.
Avoid unregulated international suppliers and check pharmacy registration badges when ordering online.
Dispensing Checklist And Pharmacist Counselling Points
Must‑Cover Points At Supply And Follow‑Up
- Confirm indication and intended duration of therapy before supply.
- Check for absolute contraindications such as hypersensitivity and concurrent rilpivirine.
- Confirm hepatic status and advise dose adjustments in moderate impairment.
- Counsel on administration: swallow capsules whole; do not chew or crush.
- Advise on missed dose and overdose procedures: do not double up; seek emergency care for overdose.
- Discuss long‑term risks such as magnesium/B12 deficiency and fracture risk with prolonged high‑dose use.
- Document counselling in the patient medication record and flag repeat supplies beyond recommended durations for review.
Provide a printable one‑page checklist and an FAQ leaflet on the product page for patients to take home.
Switching, Step‑Therapy And Comparative Pricing Strategy
When To Switch From Other PPIs And How To Present Choice
Most PPIs are therapeutically interchangeable for acid suppression, but Dexilant’s dual delayed‑release and adolescent licence can justify choice in specific patients.
Consider step‑therapy: start with a standard, lower‑cost PPI such as omeprazole and escalate to Dexilant where adherence problems, night‑time control or adolescent dosing justify the premium.
| Feature | Dexilant (Dexlansoprazole) | Omeprazole / Esomeprazole / Pantoprazole |
|---|---|---|
| Typical Dose | 30mg / 60mg | Varies; omeprazole 20mg commonly used |
| Meal Timing | More flexible due to dual release | Often requires dosing before meals for optimal effect |
| Adolescent Licence | Licensed ≥12 years | Licence varies by agent |
| Typical Cost | Higher for branded product | Generally lower for generics |
On product pages provide clear cost‑benefit bullets so patients understand adherence and lifestyle advantages against a price premium.
Product Page SEO, Compliance Content And UX Elements
Required Content Blocks, Keywords And Trust Signals
What should a compliant and conversion‑focused product page include?
Essential elements: clear product title (Dexilant — dexlansoprazole 30mg/60mg), INN, indications, dosage table, contraindications, side effects, storage instructions, legal status (Rx Only) and manufacturer information.
Include links to MHRA and SmPC where available, a downloadable patient leaflet PDF and a pharmacist contact option for queries.
Trust signals such as registered UK pharmacy badges and secure payment icons help conversion and regulatory confidence.
Wireframe Suggestions
- Hero block: product image, clear Rx only callout, price and “add to basket” for private purchase.
- Information column: INN, dose table, SmPC and patient leaflet download.
- Clinical block: indications, contraindications, side effects and interactions with a pharmacist contact CTA.
- Trust block: MHRA/SmPC links, registered pharmacy badge, FAQ schema and review snippets.
Sample meta title: Dexilant (Dexlansoprazole) 30mg / 60mg Capsules — Prescription PPI UK.
Sample meta description: Dexilant capsules for GERD and erosive oesophagitis; licensed from age 12; dual delayed‑release for flexible dosing. Rx only. Check SmPC and order via registered pharmacy.
Delivery Across United Kingdom
| City | Region | Delivery time |
|---|---|---|
| London | England | 5-7 days |
| Birmingham | England | 5-7 days |
| Manchester | England | 5-7 days |
| Glasgow | Scotland | 5-7 days |
| Leeds | England | 5-7 days |
| Liverpool | England | 5-7 days |
| Edinburgh | Scotland | 5-7 days |
| Bristol | England | 5-7 days |
| Sheffield | England | 5-9 days |
| Newcastle Upon Tyne | England | 5-7 days |
| Nottingham | England | 5-9 days |
| Leicester | England | 5-9 days |
| Coventry | England | 5-9 days |
| Belfast | Northern Ireland | 5-7 days |
| Cardiff | Wales | 5-7 days |
Final Notes For Pharmacists And Patients
Practical Tips For The Community Setting
When dispensing, always verify indication, duration and relevant comedications, and record counselling in the PMR.
Use the dosing and contraindication tables to support prescriber queries and to explain differences versus omeprazole or esomeprazole.
For patients worried about long‑term risks, discuss the lowest effective dose and the planned review date for any repeat prescription.
Encourage patients to report new or worsening GI alarm symptoms so that underlying conditions such as gastric malignancy can be ruled out prior to prolonged acid suppression.
